Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
Cyanotech Corporation (CYAN)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/31/2025: CYAN (1-star) is a SELL. SELL since 5 days. Simulated Profits (-15.00%). Updated daily EoD!
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -37.78% | Avg. Invested days 27 | Today’s Advisory SELL |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/31/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 2.53M USD | Price to earnings Ratio - | 1Y Target Price 14 |
Price to earnings Ratio - | 1Y Target Price 14 | ||
Volume (30-day avg) - | Beta -0.24 | 52 Weeks Range 0.23 - 0.89 | Updated Date 06/29/2025 |
52 Weeks Range 0.23 - 0.89 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.45 |
Earnings Date
Report Date 2025-06-20 | When - | Estimate - | Actual -0.09 |
Profitability
Profit Margin -13.23% | Operating Margin (TTM) -7.18% |
Management Effectiveness
Return on Assets (TTM) -6.16% | Return on Equity (TTM) -30.95% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 14199886 | Price to Sales(TTM) 0.1 |
Enterprise Value 14199886 | Price to Sales(TTM) 0.1 | ||
Enterprise Value to Revenue 0.59 | Enterprise Value to EBITDA 21.94 | Shares Outstanding 7232220 | Shares Floating 4836617 |
Shares Outstanding 7232220 | Shares Floating 4836617 | ||
Percent Insiders 38.34 | Percent Institutions - |
Upturn AI SWOT
Cyanotech Corporation
Company Overview
History and Background
Cyanotech Corporation was founded in 1983 and is a world leader in the production of high-value, natural products derived from microalgae. Its primary focus is on the cultivation and harvesting of microalgae for human health and nutrition. A significant milestone was the establishment of its facility on the island of Hawaii, leveraging the pristine environmental conditions for optimal algal growth. The company has evolved to become a key supplier of specialized ingredients for the dietary supplement and functional food industries.
Core Business Areas
- Spirulina Products: Cultivation, processing, and sale of Hawaiian Pacifica Spirulina, a nutrient-dense blue-green algae known for its high protein, vitamin, and mineral content. Used in supplements and functional foods.
- Astaxanthin Products: Cultivation, processing, and sale of BioAstin Natural Astaxanthin, a potent antioxidant derived from *Haematococcus pluvialis* microalgae. Marketed for its benefits in eye health, skin health, and athletic performance.
Leadership and Structure
Cyanotech Corporation is led by a management team with extensive experience in the biotechnology and nutritional supplement industries. The company operates with a lean organizational structure focused on research and development, cultivation, processing, and sales and marketing. Specific leadership details would require up-to-date information from their investor relations.
Top Products and Market Share
Key Offerings
- Hawaiian Pacifica Spirulina: A premium spirulina powder and tablet product marketed for its superior nutritional profile and purity due to its cultivation environment. Competitors include Earthrise Nutritionals and NOW Foods. Market share data for this specific product is not readily available publicly, but the spirulina market is competitive.
- BioAstin Natural Astaxanthin: A leading brand of natural astaxanthin, recognized for its quality and efficacy in antioxidant and anti-inflammatory applications. Competitors include Fuji Chemical Industries and DSM. Cyanotech is a significant player in the natural astaxanthin market.
Market Dynamics
Industry Overview
Cyanotech operates within the rapidly growing global nutraceutical and dietary supplement market, specifically focusing on microalgae-derived ingredients. This industry is driven by increasing consumer awareness of health and wellness, demand for natural and sustainable products, and a growing elderly population seeking preventative health solutions. The market for specialized ingredients like spirulina and astaxanthin is experiencing robust growth.
Positioning
Cyanotech is positioned as a premium producer of microalgae-based ingredients, leveraging its unique cultivation location on the island of Hawaii to ensure high quality and purity. Its competitive advantages include proprietary cultivation and harvesting techniques, a strong brand reputation for quality (BioAstin), and a focus on science-backed product development. The company benefits from being one of the few large-scale producers of natural astaxanthin and high-quality spirulina.
Total Addressable Market (TAM)
The global nutraceutical market is valued in the hundreds of billions of dollars and continues to grow. The specific segments for microalgae ingredients, including spirulina and astaxanthin, represent a significant portion of this TAM. Cyanotech is a niche player within this broad market, focusing on high-value, specialized ingredients. Its position is strong within its specific microalgae product categories, but it represents a small fraction of the overall health and wellness market.
Upturn SWOT Analysis
Strengths
- Proprietary cultivation technology for microalgae.
- Prime cultivation location in Hawaii, offering pristine growing conditions.
- Strong brand recognition for BioAstin Natural Astaxanthin.
- High-quality, pure products with scientifically validated benefits.
- Established distribution channels in key markets.
Weaknesses
- Limited product diversification beyond two main ingredient types.
- Reliance on specific environmental conditions, which can be subject to change.
- Relatively small market capitalization compared to larger competitors.
- Potential for production scaling challenges.
- Sensitivity to raw material costs and energy prices.
Opportunities
- Growing consumer demand for natural and plant-based health supplements.
- Expansion into new geographic markets.
- Development of new microalgae strains or applications.
- Increased research into the health benefits of their products.
- Partnerships with larger food and beverage companies for functional ingredient integration.
Threats
- Intensifying competition from both established and emerging players.
- Regulatory changes affecting the dietary supplement industry.
- Negative publicity or scientific controversies surrounding algae-based products.
- Economic downturns impacting consumer spending on discretionary health products.
- Environmental challenges such as droughts or extreme weather impacting cultivation.
Competitors and Market Share
Key Competitors
- Earthrise Nutritionals (US Stock Symbol: ERTH)
- NOW Foods (Not a publicly traded company)
- Fuji Chemical Industries (Not a publicly traded company)
- DSM (US Stock Symbol: DSM - Parent company of AlgaPrime)
Competitive Landscape
Cyanotech holds a significant position in the natural astaxanthin market with its BioAstin brand, often considered a premium offering. In the spirulina market, it faces competition from larger, established players as well as smaller niche producers. Its advantage lies in its unique Hawaiian cultivation site, which underpins product quality and a strong brand narrative. However, price competition from less premium or synthetically derived alternatives can be a challenge.
Growth Trajectory and Initiatives
Historical Growth: Cyanotech has demonstrated consistent efforts to grow its revenue through market penetration and by expanding the applications of its core products. Historical growth has been influenced by market demand for natural health ingredients and the company's ability to scale production.
Future Projections: Future projections are contingent on continued market growth for microalgae-based ingredients, successful product development, and effective sales and marketing strategies. Analyst estimates would provide forward-looking revenue and earnings growth expectations, likely in the moderate to high single-digit percentages, assuming favorable market conditions.
Recent Initiatives: Recent initiatives likely focus on optimizing production efficiency, expanding marketing efforts for BioAstin and Spirulina, and exploring new market segments or product formulations. Strategic partnerships and continued R&D into the benefits of their algae strains are also probable initiatives.
Summary
Cyanotech Corporation is a specialized producer of high-value microalgae ingredients, notably BioAstin Natural Astaxanthin and Hawaiian Pacifica Spirulina. The company's strengths lie in its premium product quality, unique cultivation environment, and established brand recognition in specific niches. However, it faces challenges related to limited product diversification and intense competition. Continued growth will depend on capitalizing on the expanding nutraceutical market and potentially exploring new product applications or strategic partnerships.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Cyanotech Corporation Investor Relations
- Industry reports on nutraceuticals and microalgae markets
- Financial data providers (e.g., Yahoo Finance, Bloomberg - if access is available)
- Company press releases and annual reports
Disclaimers:
This analysis is based on publicly available information and general industry knowledge. It is not intended as investment advice. Financial data, market share, and competitor information are subject to change and may not be exhaustive. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cyanotech Corporation
Exchange NASDAQ | Headquaters Kailua-Kona, HI, United States | ||
IPO Launch date 1993-06-22 | President, CEO & Director Mr. Matthew Keith Custer | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 83 | Website https://www.cyanotech.com |
Full time employees 83 | Website https://www.cyanotech.com | ||
Cyanotech Corporation, an agricultural company, engages in the production of natural products derived from microalgae worldwide. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint, brain, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of protein, antioxidant carotenoids, and essential nutrients. It also provides contract extraction and research and development services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health food, cosmetic manufacturers and nutraceuticals, and dietary supplement markets. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.